A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus ® in Healthy Male Volunteers

Conditions:   Type 1 Diabetes Mellitus;   Type 2 Diabetes Mellitus Interventions:   Drug: HEC-Glargine;   Drug: US-Lantus Sponsors:   Lannett Company, Inc.;   Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials